Description:

GOG-0258 Cycle Dose Drug Form (D2R) Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer NCT00942357 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=644E6D14-3E4C-95F3-E040-BB89AD4357FF

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=644E6D14-3E4C-95F3-E040-BB89AD4357FF

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/8/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Cycle Dose Drug Form (D2R) Endometrial Cancer (NCT00942357)

No Instruction available.

  1. StudyEvent: GOG-0258 Cycle Dose Drug Form (D2R)
    1. No Instruction available.
Header Module
Treatment Cycle And Modification
Cycle Delayed?
Cycle delayed reason
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
Kg
m2
Performance status (Zubrod)
Pretreatment Hematology And Chemistry Values
g/dL
1000/uL
1000/uL
1000/uL
seconds
mg/dL
mg/dL

Similar models